We are not revealing anything new if we say that there are two topics on the agenda of the vast majority of companies in the pharmaceutical industry today: omnichannel and artificial intelligence.
Applying AI/ML techniques to accelerate the acquisition and integration of structured and unstructured data, ultimately generating deeper, more relevant insights in a compliant framework.
